Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K/A - Adynxx, Inc. | tv492467-10ka.htm |
| EX-31.2 - EXHIBIT 31.2 - Adynxx, Inc. | tv492467_ex31-2.htm |
EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULES 13a-14(A) AND 15d-14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934
PURSUANT TO RULES 13a-14(A) AND 15d-14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934
I, David Johnson, certify that:
1.
I have reviewed this amendment to the Annual Report on Form 10-K of Alliqua BioMedical, Inc. (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
| | Date: April 30, 2018 | | | By: | | | /s/ David Johnson | |
| | | | | | | | David Johnson Chief Executive Officer (Principal Executive Officer) |
|